通过Redox氧物种介导的JAK2/STAT3信号通路诱导的塞伦迪亚佐尔诱导的全细胞亡
Yi Yuan1, Yinghua Li1, Qinglin Deng2
1Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510120, China.
ACS omega
|May 20, 2024
概括
塞莱纳迪亚通过增加活性氧物种 (ROS) 和诱导亡,对宫癌治疗具有前景. 这种机制涉及JAK2/STAT3通路,提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 宫癌仍然是全球主要的健康挑战.
- 新型治疗策略对于有效治疗至关重要.
- 塞伦迪亚醇已经证明了潜在的抗瘤作用.
研究的目的:
- 调查塞莱纳迪亚在宫癌中的治疗机制.
- 为了探索塞莱纳迪亚对希拉细胞的影响.
- 确定涉及塞莱纳醇抗癌活性的关键途径.
主要方法:
- 使用CCK-8试验评估的细胞活力.
- 用JC-1染色评估的线粒体膜潜力.
- 分析了亡,ROS水平和蛋白质激活 (西式涂抹).
主要成果:
- 二醇显著增加了Hela细胞中的细胞内活性氧物种 (ROS).
- ROS诱导与线粒体亡的增加相关 (AnnexinV,JC-1单体,caspase-9,BCL-2).
- 观察到JAK2/STAT3通路的激活.
结论:
- 二通过提高ROS和诱导线粒体亡来抑制宫癌细胞的生长.
- 该JAK2 / STAT3通路与塞莱纳迪亚的抗癌作用有关.
- 为了治疗的发展,需要对单二醇的机制进行进一步的研究.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


